Sfoglia per AUTORE
HERBST R
Collezione AOU San Luigi di Orbassano

  

Items : 7

5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel for Previously Treated, Programmed Death Ligand 1-Positive Advanced Non-Small-Cell Lung Cancer. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2021 May 25:S1556-0864(21)02172-9. doi: 10.1016/j.jtho.2021.05.001.

2021
AOU San Luigi di Orbassano

Herbst RS; Garon EB; Kim DW; Cho BC; Gervais R; Perez-Gracia JL; Han JY; Majem M; Forster MD; Monnet I; Novello S; Gubens MA; Boyer M; Su WC; Samkari A; Jensen EH; Kobie J; Piperdi B; Baas P;

Outcomes With Pembrolizumab Monotherapy in Patients With Programmed Death-Ligand 1-Positive NSCLC With Brain Metastases: Pooled Analysis of KEYNOTE-001, 010, 024, and 042. in JTO clinical and research reports / JTO Clin Res Rep. 2021 Jul 1;2(8):100205. doi: 10.1016/j.jtocrr.2021.100205. eCollection 2021 Aug.

2021
AOU San Luigi di Orbassano

Mansfield AS; Herbst RS; de Castro G Jr; Hui R; Peled N; Kim DW; Novello S; Satouchi M; Wu YL; Garon EB; Reck M; Robinson AG; Samkari A; Piperdi B; Ebiana V; Lin J; Mok TSK;

FP13.01 5-Year Survival Update From KEYNOTE-010: Pembrolizumab Versus Docetaxel in Previously Treated, PD-L1–Positive Advanced NSCLC in Journal of Thoracic Oncology

2021
AOU San Luigi di Orbassano

Herbst R; Garon E; Kim D; Cho BC; Gervais R; Perez-Gracia JL; Han J; Majem M; Forster MD; Monnet I; Novello S; Gubens MA; Boyer M; Su W; Samkari A; Jensen EH; Piperdi B; Baas P;

Long-Term Outcomes and Retreatment Among Patients With Previously Treated, Programmed Death-Ligand 1?Positive, Advanced Non?Small-Cell Lung Cancer in the KEYNOTE-010 Study. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2020 May 10;38(14):1580-1590. doi: 10.1200/JCO.19.02446. Epub 2020 Feb 20.

2020
AOU San Luigi di Orbassano

Gubens MA; Su WC; Szalai Z; Novello S; Monnet I; Forster MD; Majem M; Arvis CD; Han JY; Perez-Gracia JL; Cho BC; Kim DW; Garon EB; Herbst RS; Ceresoli GL; Samkari A; Jensen EH; Lubiniecki GM; Baas P;

Immune Checkpoint Inhibitors in Thoracic Malignancies: Review of the Existing Evidence by an IASLC Expert Panel and Recommendations. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2020 Jun;15(6):914-947. doi: 10.1016/j.jtho.2020.03.006. Epub 2020 Mar 14.

2020
AOU San Luigi di Orbassano

Skoulidis F; Schalper KA; Popat S; Paz-Ares L; Mezquita L; Lu S; Kubota K; Horn L; Herbst RS; Goldberg SB; Gettinger S; Forde PM; Garon EB; Barlesi F; Ahn MJ; Passiglia F; Remon J; Reck M; Adjei AA; Scagliotti GV;

Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2018 Sep;13(9):1248-1268. doi: 10.1016/j.jtho.2018.05.030. Epub 2018 Jun 6.

2018
AOU San Luigi di Orbassano

Rolfo C; Mack PC; Scagliotti GV; Baas P; Barlesi F; Bivona TG; Herbst RS; Mok TS; Peled N; Pirker R; Raez LE; Reck M; Riess JW; Sequist LV; Shepherd FA; Sholl LM; Tan DSW; Wakelee HA; Wistuba II; Wynes MW; Carbone DP; Hirsch FR; Gandara DR;

Scientific Advances in Lung Cancer 2015. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2016 May;11(5):613-638. doi: 10.1016/j.jtho.2016.03.012. Epub 2016 Mar 22.

2016
AOU San Luigi di Orbassano

Tsao AS; Scagliotti GV; Bunn PA Jr; Carbone DP; Warren GW; Bai C; de Koning HJ; Yousaf-Khan AU; McWilliams A; Tsao MS; Adusumilli PS; Rami-Porta R; Asamura H; Van Schil PE; Darling GE; Ramalingam SS; Gomez DR; Rosenzweig KE; Zimmermann S; Peters S; Ignatius Ou SH; Reungwetwattana T; Jänne PA; Mok TS; Wakelee HA; Pirker R; Mazières J; Brahmer JR; Zhou Y; et alii...